Photo of Stephanie I. Bice
R United States House · District 5 · Oklahoma On the 2026 ballot

Rep. Stephanie I. Bice

Compare
Total votes
2,818
all sessions
Attendance
100%
14 missed
Near the chamber average
With party
95%
of cast votes
Near the chamber average
Bipartisan score
3%
crosses aisle rarely
Near the chamber average
Sponsored
888
bills & resolutions
Near the chamber average
Committees
6
assignments
888 bills and resolutions

Sponsored bills

Total
888
Primary
83
Co-sponsor
805
This page
888
matching current filters
Co-sponsor HRES 1475
In committee · United States House · Co-sponsor
Expressing support for the designation of the first week of August as "National Community Health Center Week", and encouraging all Americans to participate by visiting their local community health center and celebrating the important partnership between health centers and the communities they serve.

Maddy summaryThis resolution expresses support for designating the first week of August as National Community Health Center Week to honor the contributions of these facilities. It encourages all Americans to visit their local health centers during this time to celebrate the partnership between these organizations and the communities they serve. The bill highlights how community health centers provide affordable, comprehensive care to millions of people, particularly in rural and underserved areas, while integrating services like dental care, behavioral health, and pharmacy support. By recognizing these centers, the resolution aims to raise awareness of their role in improving public health outcomes and supporting local economies.

In committee Aug 3, 2026 1 co-sponsor
Co-sponsor HR 7831
Passed · United States House · Co-sponsor
License to Drill Act

Maddy summaryThis bill, known as the License to Drill Act, extends the deadline for collecting fees on new oil and gas drilling permit applications from 2026 to 2037 under the Mineral Leasing Act. It requires the Secretary of the Interior to continue collecting these fees for each new permit application throughout the extended period. The bill also directs that all fees collected between fiscal years 2027 and 2037 be transferred to the BLM Permit Processing Improvement Fund instead of being distributed as previously required. These changes affect the Bureau of Land Management's administrative process for managing oil and gas leasing on federal lands.

Passed Jul 29, 2026 1 co-sponsor
Co-sponsor HR 9923
In committee · United States House · Co-sponsor
Biotechnology Diplomacy and Expertise Enhancement Act of 2026

Maddy summaryThis bill expands the State Department's Regional Technology Officer program to specifically include experts in biotechnology and emerging life sciences. It mandates that these officers receive specialized training in areas such as gene editing, biosecurity, and international biotechnology regulations to better support U.S. foreign policy goals. The legislation requires the Secretary of State to hire biotechnology-focused officers by fiscal year 2026 and submit a detailed implementation plan to Congress within 180 days. Additionally, the bill creates an exemption from hiring freezes to allow the Department to recruit the necessary personnel and establishes a requirement for annual reports on the program's progress and diplomatic outcomes.

In committee Jul 23, 2026 1 co-sponsor
Co-sponsor HR 8205
Passed · United States House · Co-sponsor
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

Maddy summaryThis bill reauthorizes and expands the Accelerating Access to Critical Therapies for ALS Act through 2031, extending funding for research into treatments for amyotrophic lateral sclerosis. It requires drug manufacturers to share interim clinical trial data with the FDA to better assess the progress of investigational drugs and clarifies that phase 3 clinical trial definitions include combined phase 2/3 trials and planned trials not yet enrolling participants. The legislation also mandates the FDA to publish an updated five-year action plan for ALS and other rare neurodegenerative diseases, including resource needs and coordination strategies with broader disease communities. Additionally, the bill requires the Government Accountability Office to submit a report on the program's implementation four years after enactment.

Passed Jul 23, 2026 1 co-sponsor
Co-sponsor HR 9858
In committee · United States House · Co-sponsor
STRATA Act of 2026

Maddy summaryThe STRATA Act of 2026 establishes a new program within the Department of State to foster international partnerships focused on advancing critical minerals technologies, aiming to strengthen U.S. supply chains and national security. This initiative allows the Secretary of State to form alliances with allied and partner nations, universities, and private companies while explicitly prohibiting collaborations with designated countries of concern such as China and Russia. Key provisions include the creation of International Centers of Excellence for research and training, the development of a digital platform to connect stakeholders with funding opportunities, and the establishment of clear guidelines for intellectual property and data security within these partnerships. The program authorizes the use of specific funding sources to support joint projects in extraction, recycling, and manufacturing, with a requirement that all activities conclude within ten years of the bill's enactment.

In committee Jul 22, 2026 1 co-sponsor
Co-sponsor HR 6213
In committee · United States House · Co-sponsor
Heat Workforce Standards Act of 2025

Maddy summaryHR 6213, the Heat Workforce Standards Act of 2025, prohibits the U.S. Department of Labor from finalizing, implementing, or enforcing OSHA's proposed "Heat Injury and Illness Prevention" standard (published August 30, 2024). This bill directly blocks the specific regulatory proposal targeting heat safety in both outdoor and indoor work settings. It does not create new requirements or affect workers; it solely prevents the implementation of the existing OSHA proposal. The bill is procedural, focusing on halting a regulatory action rather than establishing new policy.

In committee Jul 21, 2026 1 co-sponsor
Co-sponsor HR 1266
In committee · United States House · Co-sponsor
Combating Illicit Xylazine Act

Maddy summaryHR 1266, the Combating Illicit Xylazine Act, adds xylazine - a veterinary sedative increasingly found in illicit drug mixtures - to Schedule III of the Controlled Substances Act, regulating its use and trafficking. It directly affects veterinarians, animal owners, and manufacturers by allowing xylazine to be legally dispensed for animal use under specific veterinary prescriptions, while prohibiting non-veterinary human use. The bill includes transition periods (60 days for practitioners, 1 year for labeling) to ease compliance for manufacturers and practitioners, and requires the DEA and FDA to expedite necessary applications. It also mandates two congressional reports on xylazine's illicit use and trafficking patterns, and directs the Sentencing Commission to review penalties for offenses involving xylazine.

In committee Jul 21, 2026 1 co-sponsor
Co-sponsor HR 7184
In committee · United States House · Co-sponsor
PRESS Act

Maddy summaryHR 7184, the PRESS Act, targets equipment used to manufacture illegal drugs by making it unlawful to sell specific items like tableting machines, gelatin capsules, or related chemicals when the seller knows the equipment will be used to produce controlled substances for unlawful U.S. importation. It directly affects manufacturers and distributors of these drug-making tools who have knowledge or reasonable cause to believe their products will facilitate illegal drug trafficking. The bill adds new prohibitions to the Controlled Substances Act and increases potential prison sentences for violations, with penalties reaching up to 20 years for major offenses involving large quantities of equipment or chemicals. These changes aim to disrupt the supply chain for illicit synthetic drugs by holding equipment sellers accountable for their intended use.

In committee Jul 15, 2026 1 co-sponsor
Co-sponsor HR 3514
In committee · United States House · Co-sponsor
Improving Seniors’ Timely Access to Care Act of 2025

Maddy summaryThis bill requires Medicare Advantage plans to implement electronic pre-approval systems for medical services by 2028 and meet transparency reporting standards starting in 2027. Plans must publicly report data on approval/denial rates, appeal outcomes, response times, and technology use for pre-approval requests, including details on how denials relate to clinical criteria. It establishes a 24-hour response timeframe for certain requests and mandates annual reviews of pre-approval requirements based on data and input from seniors and providers. The law directly affects Medicare Advantage plans, seniors enrolled in these plans, and healthcare providers who submit pre-approval requests. These changes aim to make the pre-approval process faster, more transparent, and more accountable for seniors seeking covered medical services.

In committee Jul 15, 2026 1 co-sponsor
Co-sponsor HR 139
Passed · United States House · Co-sponsor
Sunshine Protection Act of 2025

Maddy summaryThe Sunshine Protection Act of 2025 would make daylight saving time permanent across the United States, ending the current practice of changing clocks twice yearly. It repeals the 1966 law requiring seasonal time changes and adjusts time zone offsets to reflect permanent daylight saving time (e.g., shifting from "4 hours" to "3 hours" in historical references). States that currently opt out of daylight saving time (like Arizona and Hawaii) would retain their existing arrangements, while all other states would adopt permanent daylight saving time unless they choose to stay on standard time. This change would directly affect all U.S. residents by eliminating the need to reset clocks in spring and fall.

Passed Jul 15, 2026 1 co-sponsor
Showing 11 to 20 of 888 bills